Peter Carney

Peter Carney

White & Case LLP

Contact
View Bio
RSS

Latest Posts › Biosimilars

Share:

What’s next for drug pricing in the US?

New challenges may lie ahead for the pharmaceutical industry - What’s next for drug pricing in the US? Proposals to alter antitrust and patent laws may signal a renewed focus on drug pricing by federal lawmakers,...more

6/18/2021  /  Biosimilars , Drug Pricing , Health Care Providers , Pharmaceutical Industry , Pharmacies , Pharmacy Benefit Manager (PBM) , Prescription Drugs
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide